Literature DB >> 3349494

Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder.

T Kakizoe1, K Tobisu, K Takai, Y Tanaka, K Kishi, S Teshima.   

Abstract

A total of 186 cystectomized specimens were examined by step-sectioning to determine the relation between papillary and nodular transitional cell carcinomas of the urinary bladder. Tumors were classified as papillary (PC), nodular (NC), and carcinoma in situ (CIS) according to their gross and microscopic configurations. These cases, grouped as simple combinations of PC, NC, and CIS, namely, PC, PC + CIS, PC + NC, PC + NC + CIS, NC, NC + CIS, and CIS, were analyzed with respect to (a) the time from the initial symptom to cystectomy, (b) the treatment before cystectomy, (c) the grade, (d) the stage of tumors, (e) the multiplicity of tumors, (f) the presence of papillary structures inside or on the surface of nodular carcinoma, and (g) data on survival after cystectomy. Of the tumors, 17 were classified as CIS and 80 as PC and PC + CIS. Studies on 57 cases suggested an early change from PC to a mixture of PC and NC through papillonodular carcinoma during development, whereas 6 showed late development of NC during repeated recurrence of PC. These courses indicate that some cases of NC developed from PC. On the other hand, 26 cases exhibited direct progression from CIS to NC. Thus nodular invasive carcinomas may develop in two ways: by emergence of a more anaplastic cell population within a preexisting low grade papillary carcinoma; and by de novo development of an invasive nodular carcinoma directly from CIS.

Entities:  

Mesh:

Year:  1988        PMID: 3349494

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Analysis of tissue ABH antigens in superficial bladder tumours.

Authors:  H Tsujihashi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Growth fraction of human bladder tumors.

Authors:  H Tsujihashi; A Nakanishi; H Matsuda; S Uejima; T Kurita
Journal:  Urol Res       Date:  1991

3.  The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.

Authors:  J C Angulo; J I Lopez; N Flores; J D Toledo
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Clinical assessment of carcinoma in situ of the human urinary bladder.

Authors:  H Tsujihashi; A Nakanishi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

5.  Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations.

Authors:  Naotaka Nishiyama; Eri Arai; Ryo Nagashio; Hiroyuki Fujimoto; Fumie Hosoda; Tatsuhiro Shibata; Taiji Tsukamoto; Sana Yokoi; Issei Imoto; Johji Inazawa; Yae Kanai
Journal:  Carcinogenesis       Date:  2010-12-22       Impact factor: 4.944

6.  Activation of PPARγ in bladder cancer via introduction of the long arm of human chromosome 9.

Authors:  Ryutaro Shimizu; Takahito Ohira; Takuki Yagyu; Tetsuya Yumioka; Noriya Yamaguchi; Hideto Iwamoto; Shuichi Morizane; Katsuya Hikita; Masashi Honda; Atsushi Takenaka; Hiroyuki Kugoh
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967

Review 7.  The role of a second transurethral resection for high-grade bladder cancer.

Authors:  P Langenstroer; W See
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

8.  Analysis by step sectioning of early invasive bladder cancer with special reference to G3.pT1 disease.

Authors:  T Kakizoe; K Tobisu; T Mizutani; M Tsutsumi; Y Tanaka; M Sakamoto
Journal:  Jpn J Cancer Res       Date:  1992-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.